Johnson & Johnson says it can produce 20M doses of COVID-19 vaccine by late March

Johnson & Johnson said Tuesday it can produce 20 million doses of the single-shot coronavirus vaccine by late March and has applied for emergency authorization by the Food and Drug Administration.